A PROSPECTIVE, RANDOMIZED CONTROLLED TRIAL EVALUATING OVERALL SURVIVAL IN PATIENTS WITH PRIMARY BONE METASTATIC PROSTATE CANCER (MPCA) RECEIVING EITHER ANDROGEN DEPRIVATION THERAPY (ADT) OR ADT COMBINED WITH CONCURRENT RADIATION THERAPY TO THE PROSTATE, FINAL DATA FROM THE HORRAD TRIAL

Liselotte Boeve, Maarten Hulshof, Andre Vis, Koos Zwinderman, Jos Twisk, Karl Delaere, Jeroen van Moorselaar, Paul Verhagen, George van Andel

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)E231-E232
JournalJournal of Urology
Volume199
Issue number4
Publication statusPublished - Apr 2018

Cite this